Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2000 4
2001 1
2002 4
2003 4
2004 4
2005 4
2007 5
2008 4
2009 7
2010 2
2011 3
2012 4
2013 7
2014 3
2015 2
2016 3
2017 3
2018 4
2019 2
2020 3
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Reply.
Sobol EK, Francis JH, Abramson DH, Freund KB, Spaide RF, Barbazetto I. Sobol EK, et al. Among authors: barbazetto i. Retina. 2021 Feb 1;41(2):e24. doi: 10.1097/IAE.0000000000003034. Retina. 2021. PMID: 33230066 No abstract available.
Ocular changes during pregnancy.
Barbazetto IA, Pizzarello LD. Barbazetto IA, et al. Compr Ophthalmol Update. 2007 May-Jun;8(3):155-67. Compr Ophthalmol Update. 2007. PMID: 17651545 Review.
Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E, Bottini A, Ghadiali Q, Balaratnasingam C, Barbazetto I. Tsui E, et al. Among authors: barbazetto i. Ocul Immunol Inflamm. 2018;26(8):1297-1300. doi: 10.1080/09273948.2017.1353638. Epub 2017 Oct 11. Ocul Immunol Inflamm. 2018. PMID: 29020488
Central serous chorioretinopathy in myopic patients.
Yzer S, Fung AT, Barbazetto I, Yannuzzi LA, Freund KB. Yzer S, et al. Among authors: barbazetto i. Arch Ophthalmol. 2012 Oct;130(10):1339-40. doi: 10.1001/archophthalmol.2012.850. Arch Ophthalmol. 2012. PMID: 23044956 No abstract available.
Macular dystrophy in Heimler syndrome.
Lima LH, Barbazetto IA, Chen R, Yannuzzi LA, Tsang SH, Spaide RF. Lima LH, et al. Among authors: barbazetto ia. Ophthalmic Genet. 2011 Jun;32(2):97-100. doi: 10.3109/13816810.2010.551797. Epub 2011 Mar 2. Ophthalmic Genet. 2011. PMID: 21366429 Free PMC article.
76 results